A Qualitative Assessment of Eating Behaviors in Adults with Autism
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Vol 3:3 Properties of Proteins Relate to Their Contribution to the 168 Physiochemicalf and Sensory Properties of Foods
Popular Article Journal Home: www.bioticainternational.com Article: RT520 How to cite this article? Biotica Vinoth et al., 2021. Food Derived Peptides – Role in Research [Human Health. Biotica Research Today 3(3): 165-168. [ Today Abstract ood proteins have long been recognized for their nutritional 165 and functional properties. On the other hand, the functional Vol 3:3 properties of proteins relate to their contribution to the 168 physiochemicalF and sensory properties of foods. Nowadays, a 2021 considerable amount of research has also focused on bioactive peptides which are present in foods, and researchers are trying Food Derived Peptides – to utilize such peptides as functional food ingredients aimed at health maintenance. Several bioactive peptides such as antioxidant, Role in Human Health antihypertensive, antiproliferative, antimicrobial, neuroactive, * hormonal and mineral binding were isolated from the fishes Vinoth Kumar L. , Manivannan M. and and shellfishes. The process flow of bioactive peptides includes Vignaesh D. purification and filtration methods and the peptide sequence was identified. The commercial application were also reported and Paraprofessional Institute of Fisheries Technology, Tamil Nadu discussed by many researches. Although the efficacies of these Dr. J. Jayalalithaa Fisheries University, Madhavaram, Chennai, peptides were wide range, the safety and conditions of usage are Tamil Nadu (600 051), India yet to be proven. Introduction t has been defined as specific protein fragments that have a Open Access positive impact on body functions and conditions and may Corresponding Author Iultimately influence health. Bioactive peptides have been defined as peptides with hormone- or drug like activity that Vinoth Kumar L. e-mail: [email protected] eventually modulate physiological function through binding interactions to specific receptors on target cells leading to induction of physiological responses (Murray and Fitzgerald, 2007). -
Literature Review of Prescription Analgesics in the Causal Path to Pain
Literature Review: Opioids and Death compiled by Bill Stockdale ([email protected]) This review is the result of searches for the terms opioid/opioid-related-disorders and death/ADE done in the PubMed database. This bibliography includes selected articles from the 1,075 found by searching during May, 2008, which represent key findings in the study of opioids. Articles for which there is no abstract are excluded. Also case reports and initial clinical trial reports are excluded. This is a compendium of all articles and do not lead to a specific target. There are three major topics developed in the literature as shown in this table of contents; • Topic One: Opioids in Causal Path to Death (page 1) o Prescription Drug Deaths (page 1) o Illicit Drug Deaths (page 30) o Neonatal Deaths (page 49) • Topic Two: Deaths in Palliative Care and Pain Treatment (page 57) • Topic Three: Pharmacology, Psychology, Origins of Abuse Relating to Death (page 72) • Bibliography (page 77) The three topics are presented below; each is followed in chronological order. Topic One: Opioids in Causal Path to Death Prescription Drug Deaths Karlson et al. describe differences in treatment of acute myocardial infarction, including different opioid use among men and women. The question whether women and men with acute myocardial infarction (AMI) are treated differently is currently debated. In this analysis we compared pharmacological treatments and revascularization procedures during hospitalization and during 1 year of follow-up in 300 women and 621 men who suffered an AMI in 1986 or 1987 at our hospital. During hospitalization, the mean dose of morphine (+/- SD) during the first 3 days was higher in men compared to women (14.5 +/- 15.7 vs. -
Nutritional Interventions for Autism Spectrum Disorder
Lead Article Nutritional interventions for autism spectrum disorder Downloaded from https://academic.oup.com/nutritionreviews/advance-article-abstract/doi/10.1093/nutrit/nuz092/5687289 by Florida Atlantic University user on 06 January 2020 Elisa Karhu*, Ryan Zukerman*, Rebecca S. Eshraghi, Jeenu Mittal, Richard C. Deth, Ana M. Castejon, Malav Trivedi, Rahul Mittal, and Adrien A. Eshraghi Autism spectrum disorder (ASD) is an increasingly prevalent neurodevelopmental dis- order with considerable clinical heterogeneity. With no cure for the disorder, treat- ments commonly center around speech and behavioral therapies to improve the characteristic social, behavioral, and communicative symptoms of ASD. Gastrointestinal disturbances are commonly encountered comorbidities that are thought to be not only another symptom of ASD but to also play an active role in modulating the expression of social and behavioral symptoms. Therefore, nutritional interventions are used by a majority of those with ASD both with and without clinical supervision to alleviate gastrointestinal and behavioral symptoms. Despite a consider- able interest in dietary interventions, no consensus exists regarding optimal nutritional therapy. Thus, patients and physicians are left to choose from a myriad of dietary pro- tocols. This review, summarizes the state of the current clinical and experimental liter- ature on nutritional interventions for ASD, including gluten-free and casein-free, keto- genic, and specific carbohydrate diets, as well as probiotics, polyunsaturated fatty -
Peripherally Acting Mu-Opioid Receptor Antagonists and Postoperative Ileus: Mechanisms of Action and Clinical Applicability
Review Article Peripherally Acting Mu-Opioid Receptor Antagonists and Postoperative Ileus: Mechanisms of Action and Clinical Applicability Eugene R. Viscusi, MD* Postoperative ileus (POI), a transient cessation of coordinated bowel function after surgery, is an important health care problem. The etiology of POI is multifactorial Tong J. Gan, MD† and related to both the surgical and anesthetic pathways chosen. Opioids used to manage surgical pain can exacerbate POI, delaying gastrointestinal (GI) recovery. John B. Leslie, MD, MBA‡ Peripherally acting mu-opioid receptor (PAM-OR) antagonists are designed to mitigate the deleterious effects of opioids on GI motility. This new class is investigational for POI management with the goal of accelerating the recovery of Joseph F. Foss, MD§ upper and lower GI tract function after bowel resection. In this review, we summarize the mechanisms by which POI occurs and the role of opioids and opioid Mark D. Talon, CRNA receptors in the enteric nervous system, discuss the mechanism of action of PAM-OR antagonists, and review clinical pharmacology and Phase II/III POI trial Wei Du, PhD¶ results of methylnaltrexone and alvimopan. Finally, the role of anesthesiologists in managing POI in the context of a multimodal approach is discussed. Gay Owens, PharmD¶ (Anesth Analg 2009;108:1811–22) Postoperative ileus (POI) is a transient cessation of (BR), often not resolving for 4 days or longer.3 Clini- coordinated bowel motility that prevents effective cally, POI is characterized by delayed passage of flatus transit of intestinal contents or tolerance of oral in- and stool, bloating, abdominal distension, abdominal take.1,2 POI occurs universally after bowel resection pain, nausea, and vomiting and is associated with an increase in postoperative morbidity and length of 4,5 From the *Department of Anesthesiology, Jefferson Medical hospital stay (LOS). -
Efficacy and Safety of Gluten-Free and Casein-Free Diets Proposed in Children Presenting with Pervasive Developmental Disorders (Autism and Related Syndromes)
FRENCH FOOD SAFETY AGENCY Efficacy and safety of gluten-free and casein-free diets proposed in children presenting with pervasive developmental disorders (autism and related syndromes) April 2009 1 Chairmanship of the working group Professor Jean-Louis Bresson Scientific coordination Ms. Raphaëlle Ancellin and Ms. Sabine Houdart, under the direction of Professor Irène Margaritis 2 TABLE OF CONTENTS Table of contents ................................................................................................................... 3 Table of illustrations .............................................................................................................. 5 Composition of the working group ......................................................................................... 6 List of abbreviations .............................................................................................................. 7 1 Introduction .................................................................................................................... 8 1.1 Context of request ................................................................................................... 8 1.2 Autism: definition, origin, practical implications ........................................................ 8 1.2.1 Definition of autism and related disorders ......................................................... 8 1.2.2 Origins of autism .............................................................................................. 8 1.1.2.1 Neurobiological -
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
Medication-Assisted Treatment For Opioid Addiction in Opioid Treatment Programs A Treatment Improvement Protocol TIP 43 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment MEDICATION- www.samhsa.gov ASSISTED TREATMENT Medication-Assisted Treatment For Opioid Addiction in Opioid Treatment Programs Steven L. Batki, M.D. Consensus Panel Chair Janice F. Kauffman, R.N., M.P.H., LADC, CAS Consensus Panel Co-Chair Ira Marion, M.A. Consensus Panel Co-Chair Mark W. Parrino, M.P.A. Consensus Panel Co-Chair George E. Woody, M.D. Consensus Panel Co-Chair A Treatment Improvement Protocol TIP 43 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment 1 Choke Cherry Road Rockville, MD 20857 Acknowledgments The guidelines in this document should not be considered substitutes for individualized client Numerous people contributed to the care and treatment decisions. development of this Treatment Improvement Protocol (see pp. xi and xiii as well as Appendixes E and F). This publication was Public Domain Notice produced by Johnson, Bassin & Shaw, Inc. All materials appearing in this volume except (JBS), under the Knowledge Application those taken directly from copyrighted sources Program (KAP) contract numbers 270-99- are in the public domain and may be reproduced 7072 and 270-04-7049 with the Substance or copied without permission from SAMHSA/ Abuse and Mental Health Services CSAT or the authors. Do not reproduce or Administration (SAMHSA), U.S. Department distribute this publication for a fee without of Health and Human Services (DHHS). -
Bioactive Compounds and Milk Peptides Forhuman Health-A Review
Novel Techniques in CRIMSON PUBLISHERS C Wings to the Research Nutrition and Food Science ISSN: 2640-9208 Review Article Bioactive Compounds and Milk Peptides for Human Health-A Review K Jayathilakan*, Rajkumar Ahirwar and MC Pandey Freeze Drying and Animal Products Technology Division, Defence Food Research Laboratory, India *Corresponding author: K Jayathilakan, Freeze Drying and Animal Product Technology Division, Defence Food Research Laboratory, Siddarthanagar, Mysore -570011, India Submission: March, 26, 2018; Published: May 08, 2018 Abstract portion of milk contains a variety of substances including lactose (milk sugar), protein (casein and whey), minerals and certain vitamins. It is a good Milk is a complex mixture and highly nutritious food for human being. It is an emulsion of fat globules in an aqueous environment. The aqueous a good source of nutrients for any neonate of mammalian species and nourishment of adult humans. Recent studies have shown that milk furnishes a broadsource range of bio ofpeptides biologically and otheractive bioactive compounds components that guard which neonates are necessary and adults for against body maintenance pathogens and and illnesses to fight againstsuch as severalimmunoglobulin, disease conditions. antibacterial It is peptides, antimicrobial proteins, oligosaccharides and lipids. Bioactive compounds are distinguished from essential nutrients which can have an Manyinfluence phenolic on health. compounds These are have extra antioxidant nutritional properties constituents and that some typically studies occur have indemonstrated small quantities favourable in foods. effects Phenolic on compounds,thrombosis andincluding tumorigenesis. their sub Conjugatedcategory, flavonoids linoleic acid,are present pre biotic, in all probiotic, plants and bio have peptides been andstudied bioactive extensively components in cereals, along legumes, with amino nuts, oliveacids oil,and vegetables, proteins molecules fruits, tea areand present red wine. -
Treating Autism Spectrum Disorder with Gluten-Free and Casein-Free Diet: the Underlying Microbio- Ta-Gut-Brain Axis Mechanisms
Cieślińska A, et al., J Clin Immunol Immunother 2017, 3: 009 DOI: 10.24966/CIIT-8844/100009 HSOA Journal of Clinical Immunology and Immunotherapy Review Article Abbreviations Treating Autism Spectrum ASD - Autism Spectrum Disorder GI - Gastrointestinal Disorder with Gluten-free and HPA - Hypothalamic-Pituitary-Adrenal Casein-free Diet: The underly- Introduction A growing number of children are diagnosed with Autism Spec- ing Microbiota-Gut-Brain Axis trum Disorder (ASD), a category of neuro developmental disorders Mechanisms such as Autism, Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) and Asperger’s disorder, collectively included 1 1 2* Anna Cieślińska , Elżbieta Kostyra and Huub FJ Savelkoul in the DSM-V criteria. The American Psychiatric Association’s Diag- 1Department of Biology and Biotechnology, University of Warmia and nostic and Statistical Manual, Fifth Edition (DSM-5) provides stan- Mazury, Olsztyn, Poland dardized criteria to help diagnose ASD [1]. The prevalence of ASD is 2Department of Cell Biology and Immunology group, Wageningen Universi- at least 1 in 160 children worldwide [2-4]. ty & Research, Wageningen, The Netherlands It is called a spectrum disorder because patients show a varying degree and severity of symptoms [1]. The most typical symptoms are deficits in social communication and interaction, along with restrict- ed interests, repetitive behaviors and a difficulty with imagination. Often, people with ASD avoid making eye contact with others, seem unresponsive to environmental cues and have difficulty to judge other people’s emotions [5-7]. Reduced pain sensitivity is often described as well [8]. The parents can often recognize these symptoms already Abstract at one year of age. -
Opioid Peptides: Medicinal Chemistry, 69
Opioid Peptides: Medicinal Chemistry DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration Opioid Peptides: Medicinal Chemistry Editors: Rao S. Rapaka, Ph.D. Gene Barnett, Ph.D. Richard L. Hawks, Ph.D. Division of Preclinical Research National Institute on Drug Abuse NIDA Research Monograph 69 1986 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 NIDA Research Monographs are prepared by the research divisions of the National Institute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute San Francisco, California Alcohol and Drug Problems Association of North America WashIngton, DC DENISE KANDEL, Ph.D. GILBERT J. BOTVIN, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V. -
Posttranscriptional Regulation of Mu Opioid Receptor (MOR-1): Implications of Alternative Splicing in the Neuropathogenesis of Morphine Tolerance
Review Article J Anest & Inten Care Med Volume 9 Issue 4 - Octomber 2019 Copyright © All rights are reserved by Alrena V Lightbourn DOI: 10.19080/JAICM.2019.09.555767 Posttranscriptional Regulation of Mu Opioid Receptor (MOR-1): Implications of Alternative Splicing in the Neuropathogenesis of Morphine Tolerance. Literature Review and Research Approach Alrena V Lightbourn* Basic & Pharmaceutical Sciences Division, Florida A&M University, USA Submission: May 28, 2018; Published: October 10, 2019 *Corresponding author: Alrena V Lightbourn, Basic & Pharmaceutical Sciences Division, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences, Tallahassee, FL, USA Abstract It is no surprise that the progressive increase in the use, misuse and abuse of prototypical narcotic analgesic, morphine, has so heightened approachesawareness within investigating scientific cellular and clinicalchanges communities and receptor that binding researchers strategies, are the clamoring wealth of to genetic discover information new and comingdivergent from approaches the Human to Genome disrupt negative opioid receptor-mediated outcomes and to improve drug efficacy toward beneficial effects. Beyond the traditional pharmacologic Enthusiasm for the contributions of alternatively spliced variants has been slow, except for the widely accepted cytochrome P450 metabolic Project provokes deeper insight to be sought at the more significant, mechanistically relevant, posttranslational and posttranscriptional levels. greater demand on scientists to elucidate the signal transduction pathways and molecular mechanisms employing these variants. The hope of discoveringenzymes. Nonetheless, functional signaturesa steadily growingfor these repository variants is of increasing recently identifiedand it appears opioid that receptor their clinical alternatively utility splicedas new andvariants relevant (ASVs) molecular places an targets even for improving opioid pharmacotherapy may gain momentum. -
Volume C, Module 2 Leader's Guide Opioids: Basics of Addiction
Volume C, Module 2 Leader’s Guide Opioids: Basics of Addiction; Treatment with Agonists, Partial Agonists, and Antagonists Treatnet Training Volume C: Module 2 – Updated 21 February 2008 1 1 Module 2: Training goals To describe the: z Key components of opiate addiction and its medical / psychiatric consequences z Benefits and limitations of methadone as a pharmacotherapy for opiate dependence z Benefits and limitations of buprenorphine as a pharmacotherapy for opiate dependence z Benefits and limitations of narcotic antagonists for overdose (naloxone) and relapse prevention (naltrexone) for opiate dependence 2 2 Module 2: Workshops Workshop 1: Opiates: What they are, problems associated with their use, and medical treatment implications Workshop 2: Opiate addiction treatment with methadone Workshop 3: Opiate addiction treatment with buprenorphine Workshop 4: Opiate Antagonist Treatment: Naloxone for overdose, Naltrexone for relapse prevention 3 3 Icebreaker: Opiate medication in my country Does your country use opiate medications, and if so, what type of medication? What are the main problems in your country regarding the use of these medications? 15 minutes 4 4 Workshop 1: Opiates What they are, problems associated with their use, and medical treatment implications 5 5 Pre-assessment Please respond to the pre-assessment questions in your workbook. (Your responses are strictly confidential.) 10 minutes 6 6 Training objectives At the end of this training you will understand the: 1. Epidemiology of opiate addiction worldwide and its relationship to infectious diseases 2. Basic neurobiology of opiate addiction 3. Medical / psychiatric co-morbidities and treatment strategies for these disorders used with opiate addicts 4. Key issues in engaging opiate addicts into treatment with low threshold approaches 7 7 Opioids Definition Opioids are natural derivatives of opium or synthetic psychoactive substances that have effects similar to morphine or are capable of converting into a drug having such effects. -
Neurotransmitters: Their Role Within the Body
Neurotransmitters: Their Role in the Body WWW.RN.ORG® Reviewed October, 2019, Expires October, 2021 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited ©2019 RN.ORG®, S.A., RN.ORG®, LLC Developed by Melissa K Slate, RN, CRN Objectives By the end of this educational encounter, the clinician will be able to: 1. Understand how nerve impulses travel along neural pathways 2. Identify common neurotransmitters and their effect in the body 3. Explain the effect of altered concentrations of specific neurotransmitters upon the system. The purpose of this course is to give an overview of the neurotransmitter system of the human body and increase understanding about how altered neurotransmitter concentrations affect various body organs. Definition of a Neurotransmitter Neurotransmitters are types of hormones in the brain that transmit information from one neuron to another. They are made by amino acids. Neurotransmitters control major body functions including movement, emotional response, and the physical ability to experience pleasure and pain. The most familiar neurotransmitters, which are thought to play a role in mood regulation, are serotonin, norepinephrine, dopamine, acetylcholine, and GABA. In order to adequately understand the effect of neurotransmitters, we must first understand what occurs in the process of neurotransmission. We will start with an oversimplified version for better understanding and then follow up with a more detailed explaination. A nerve impulse, which is an electrical signal, travels along the neural pathway until it reaches the end. Here the electrical signal is converted to a chemical signal. This area of conversion is called a synapse. The chemical signal is called a neurotransmitter.